Almut Scherer - Concepedia

Author

Almut Scherer

Also Known As

A Scherer, A. Scherer, Alexandre Scherer, Almut Scherer, Ana Alice de Araujo Scherer, Scherer Almut, Scherer, A., Scherer, Almut

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

SCQM Foundation University Hospital of Geneva University Hospital of Bern University Hospital of Zurich University Hospital of Basel

About

Almut Scherer is an author at SCQM Foundation specializing in rheumatology, ultrasound, and rheumatic diseases.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	86
2	Rheumatology	2	2	86
3	Rheumatic Diseases	2	2	86
4	Orthopaedics	1	1	49
5	Autoimmune Disease	1	1	49

Almut Scherer

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
TNF blockers inhibit spinal radiographic progression in ankylosing spondylitis by reducing disease activity: results from the Swiss Clinical Quality Management cohort Christoph Molnar, Almut Scherer, Xenofon Baraliakos, Annals of the Rheumatic Diseases	2017	249
Tumor Necrosis Factor α Inhibition in Radiographic and Nonradiographic Axial Spondyloarthritis: Results From a Large Observational Cohort Adrian Ciurea, Almut Scherer, Pascale Exer, Arthritis & Rheumatism	2013	149
Chronic NSAID use and long-term decline of renal function in a prospective rheumatoid arthritis cohort study Burkhard Möller, Menno Pruijm, Sabine Adler, Annals of the Rheumatic Diseases	2013	109
Effectiveness of biologic DMARDs in monotherapy versus in combination with synthetic DMARDs in rheumatoid arthritis: data from the Swiss Clinical Quality Management Registry Cem Gabay, Myriam Riek, Almut Scherer, Lara D. Veeken	2015	94
Impact of obesity on the response to tumor necrosis factor inhibitors in axial spondyloarthritis Raphael Micheroli, Monika Hebeisen, Lukas Wildi, Arthritis Research & Therapy	2017	85
Comparative effectiveness of antitumour necrosis factor agents, biologics with an alternative mode of action and tofacitinib in an observational cohort of patients with rheumatoid arthritis in Switzerland Axel Finckh, Christoph Tellenbach, Lisa Herzog, RMD Open	2020	64
Differential drug retention between anti-TNF agents and alternative biological agents after inadequate response to an anti-TNF agent in rheumatoid arthritis patients Sophie Martin Du Pan, Almut Scherer, Cem Gabay, Annals of the Rheumatic Diseases	2012	63
Impact of the COVID-19 pandemic on the disease course of patients with inflammatory rheumatic diseases: results from the Swiss Clinical Quality Management cohort Adrian Ciurea, Eleftherios Papagiannoulis, Kristina Bürki, Annals of the Rheumatic Diseases	2020	62
Anaemia may add information to standardised disease activity assessment to predict radiographic damage in rheumatoid arthritis: a prospective cohort study Burkhard Möller, Almut Scherer, Frauke Förger, Annals of the Rheumatic Diseases	2013	61
Impaired response to treatment with tumour necrosis factor α inhibitors in smokers with axial spondyloarthritis Adrian Ciurea, Almut Scherer, Ulrich Weber, Annals of the Rheumatic Diseases	2015	58

Page 1